Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01580267 · ClinicalTrials.gov registry record
Hepcidin and Anemia in Trauma
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 74
- Enrollment target
NCT01580267: Completed study, sponsored by University of Michigan.
NCT01580267 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01580267 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
Anemia (decreased number of red blood cells) is common in critically ill trauma patients admitted to an Intensive Care Unit and is associated with a high rate of blood transfusions. This "anemia of inflammation" is a result of three mechanisms: impaired iron regulation, shortened red blood cell life span, and reduced rate of erythropoiesis (a protein that helps make new red blood cells). Hepcidin, a protein made in the liver, regulates iron and is decreased when iron in the blood is low. This can lead to anemia. This research study is being conducted to learn how inflammation, hepcidin, and erythropoietin interact in critically ill patients. The findings will help in determining effective treatment for patients with anemia of inflammation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-04 |
What the finished NCT01580267 record still lists
NCT01580267 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01580267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01580267 about?
NCT01580267 is a clinical study titled "Hepcidin and Anemia in Trauma". Anemia (decreased number of red blood cells) is common in critically ill trauma patients admitted to an Intensive Care Unit and is associated with a high rate of blood transfusions. This "anemia of inflammation" is a result of three mechanisms: impaired iron regulation, shortened red blood cell life...
What is the current status of trial NCT01580267?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2012-06. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01580267?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia